What is it about?

Bupropion is an approved medication that has been widely used for the treatment of depressive disorders. However, the risk of inappropriate bupropion use and possibility of addiction has been underestimated. We present a case to highlight the possibility of bupropion sustained-release (SR) addiction.

Featured Image

Why is it important?

In the present report, we emphasize that the administration of dopaminergic-related stimulants should be cautiously considered treatment success and that psychiatrists should be aware of the possibility of addiction when dopaminergic drugs are administered for depression.

Read the Original

This page is a summary of: Have we underestimated the possibility of bupropion sustained-release addiction?, Australian & New Zealand Journal of Psychiatry, February 2016, SAGE Publications,
DOI: 10.1177/0004867416632928.
You can read the full text:

Read

Contributors

The following have contributed to this page